Putative antiviral effects of propofol in COVID-19

Br J Anaesth. 2021 May;126(5):e188-e191. doi: 10.1016/j.bja.2021.02.006. Epub 2021 Feb 13.
No abstract available

Keywords: COVID-19; angiotensin-converting enzyme 2; propofol; severe acute respiratory syndrome coronavirus-2; severity.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Intravenous / administration & dosage*
  • Angiotensin-Converting Enzyme 2 / biosynthesis
  • Antiviral Agents / administration & dosage*
  • COVID-19 / enzymology
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Humans
  • Propofol / administration & dosage*
  • Treatment Outcome

Substances

  • Anesthetics, Intravenous
  • Antiviral Agents
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • Propofol